T1	intervention 11 28	physical exercise
T2	eligibility 444 495	breast cancer patients during adjuvant chemotherapy
T3	total-participants 501 504	130
T9	outcome 1312 1330	Changes in fatigue
T10	outcome 1361 1392	changes in inflammatory markers
T4	outcome 903 929	IL-6 and IL-6/IL-1ra ratio
T5	outcome 1080 1102	cancer-related fatigue
